Sichuan Hebang Biotechnology Co Ltd (603077) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Sichuan Hebang Biotechnology Co Ltd (603077) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥165.40 Million ≈ $24.20 Million USD) by net assets (CN¥18.77 Billion ≈ $2.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603077 equity to assets ratio to measure how much of total assets are equity-financed.

Sichuan Hebang Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Sichuan Hebang Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603077 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Sichuan Hebang Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sichuan Hebang Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Liechtensteinische Landesbank Aktiengesellschaft F:LLS1	-0.061x
China Southern Power Grid Energy Efficiency & Clean Energy Co Ltd SHE:003035	0.087x
COFCO Capital Holdings Co Ltd SHE:002423	0.249x
Topco Scientific Co Ltd TW:5434	0.035x
Nuscale Power Corp NYSE:SMR	-0.284x
GoTo Gojek Tokopedia PT JK:GOTO	0.016x
LXP Industrial Trust NYSE:LXP	0.019x
Brookdale Senior Living Inc NYSE:BKD	-0.383x

Annual Cash Flow Conversion Efficiency for Sichuan Hebang Biotechnology Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 603077 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥19.01 Billion ≈ $2.78 Billion	CN¥467.93 Million ≈ $68.47 Million	0.025x	+147.94%
2023-12-31	CN¥20.22 Billion ≈ $2.96 Billion	CN¥200.76 Million ≈ $29.38 Million	0.010x	-92.58%
2022-12-31	CN¥19.76 Billion ≈ $2.89 Billion	CN¥2.64 Billion ≈ $386.94 Million	0.134x	-38.74%
2021-12-31	CN¥14.64 Billion ≈ $2.14 Billion	CN¥3.20 Billion ≈ $467.78 Million	0.218x	+569.51%
2020-12-31	CN¥11.31 Billion ≈ $1.65 Billion	CN¥368.85 Million ≈ $53.97 Million	0.033x	+129.32%
2019-12-31	CN¥11.45 Billion ≈ $1.68 Billion	CN¥162.92 Million ≈ $23.84 Million	0.014x	-83.13%
2018-12-31	CN¥11.20 Billion ≈ $1.64 Billion	CN¥944.39 Million ≈ $138.19 Million	0.084x	+437.35%
2017-12-31	CN¥11.27 Billion ≈ $1.65 Billion	CN¥176.94 Million ≈ $25.89 Million	0.016x	-70.60%
2016-12-31	CN¥10.78 Billion ≈ $1.58 Billion	CN¥575.26 Million ≈ $84.18 Million	0.053x	-21.77%
2015-12-31	CN¥6.58 Billion ≈ $963.21 Million	CN¥449.20 Million ≈ $65.73 Million	0.068x	+58.44%
2014-12-31	CN¥4.75 Billion ≈ $695.38 Million	CN¥204.67 Million ≈ $29.95 Million	0.043x	+134.78%
2013-12-31	CN¥3.29 Billion ≈ $481.46 Million	CN¥-407.48 Million ≈ $-59.63 Million	-0.124x	-412.44%
2012-12-31	CN¥3.40 Billion ≈ $498.22 Million	CN¥134.96 Million ≈ $19.75 Million	0.040x	-90.38%
2011-12-31	CN¥1.34 Billion ≈ $196.21 Million	CN¥552.56 Million ≈ $80.86 Million	0.412x	+21.42%
2010-12-31	CN¥974.62 Million ≈ $142.62 Million	CN¥330.77 Million ≈ $48.40 Million	0.339x	+262.97%
2009-12-31	CN¥737.62 Million ≈ $107.94 Million	CN¥68.97 Million ≈ $10.09 Million	0.094x	--

About Sichuan Hebang Biotechnology Co Ltd

SHG:603077 China Chemicals

Market Cap

$3.10 Billion

CN¥21.20 Billion CNY

Market Cap Rank

#4804 Global

#804 in China

Share Price

CN¥2.40

Change (1 day)

-1.23%

52-Week Range

CN¥1.85 - CN¥3.33

All Time High

CN¥4.69